Navigation Links
Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting

BOSTON--(BUSINESS WIRE)--May 2, 2007 - Acorda Therapeutics, Inc.(R) (Nasdaq: ACOR) today presented data from a Phase 3 clinical trial of Fampridine-SR in people with multiple sclerosis (MS) at the American Academy of Neurology meeting. Andrew Goodman, M.D., Director of the Multiple Sclerosis Center at the University of Rochester, presented top-line results on walking ability, leg strength, spasticity and clinician and subject global impressions. Dr. Goodman also presented a review of safety data.

Presentation Highlights

The prospectively-designed analysis plan for the study was based on a responder criterion, defined as a consistent improvement in walking speed, as measured with the Timed 25 Foot Walk. A significantly greater proportion of people taking Fampridine-SR were Timed Walk Responders compared to people taking placebo (34.8 percent vs. 8.3 percent, p less than 0.0001). Increased response rate with treatment was seen across all four major (relapsing and progressive) types of MS.

The mean increase in walking speed, compared to pre-treatment, for Fampridine-SR treated Timed Walk Responders was significantly greater at every visit during the treatment period, compared to both Fampridine-SR Timed Walk Non-Responders and placebo treated patients (p less than 0.0001). The average increase in walking speed over the treatment period, compared to baseline, was 25.2 percent for the drug treated Timed Walk Responders vs. 4.7 percent for the placebo group. In follow-up visits, at two and four weeks after the end of the treatment period, Responder and Non-responder groups returned to their baseline walking speeds.

The clinical significance of the consistent response on the timed walk was validated in the trial primarily by the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), a patient self-assessment of walking disability. There was a statistically significant improvement in the MSWS-12 score
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
2. Acorda Therapeutics to Host Analyst and Investor Reception
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
(Date:8/21/2014)... FRANCISCO , Aug. 21, 2014 /PRNewswire/ ... Food and Drug Administration (FDA) has granted ... detect atrial fibrillation (AFib), the most common ... process (algorithm) instantly detects if patients are ... taken on the mobile phone based AliveCor® ...
(Date:8/21/2014)... -- CVS Caremark Corporation (NYSE: CVS ) announced ... payable in connection with its previously announced cash tender offers ... any and all of its 6.250% Senior Notes due 2027 ... maximum amount of its 6.125% Senior Notes due 2039, 5.750% ... (collectively, the "Maximum Tender Offer Notes" and together with the ...
(Date:8/21/2014)... Aug. 21, 2014  The board of directors of ... provider of clinical trial imaging solutions, today announced that ... financial officer, effective immediately.  Mr. Groff has held the ... He joined VirtualScopics in January 2006 as an accounting ... "When the board of VirtualScopics asked Jim ...
Breaking Medicine Technology:AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
(Date:8/21/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:8/21/2014)... Rebecca Tabbert, owner of Calimesa Fit ... has enjoyed watching as more people turn away from ... boot camp environment. It’s not only good for her ... old ‘treadmill-dumbbells-elliptical’ routine just doesn’t work,” she says. “Numerous ... machines and lifting those cute little dumbbells does very ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 Bedros Keuilian’s ... event in the industry, attended by many people already earning ... World Conference is usually only open to the owners ... until now. , This year’s Fit Body Boot Camp World ... considering opening a fitness boot camp or are ...
(Date:8/21/2014)... IL (PRWEB) August 21, 2014 Artisan ... Business & Investment Exploratory Delegation to southern China October ... opportunity to explore the rapid growing cities of Shenzhen ... delegate will have the rare opportunity to meet with ... project(s) during a short weeklong time frame. , ...
(Date:8/21/2014)... 21, 2014 mynt welcomes industry leaders ... to join its growing company. Since its pre-launch in ... product sales and continues to gain momentum leading up ... Rob and Tiffanie came into network marketing by chance. ... number of network marketing companies. Tiffanie needed help at ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 2Health News:Calimesa Fit Body Boot Camp Announces Its Release of a New Video about the Fitness Boot Camp Experience 3Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2
... understanding of the evolution and spread of viruses like H5N1, ... a consortium, where all// information about the avian influenza will ... on Sharing Avian Influenza Data (GISAID) was announced in ... that was signed by 70 scientists and health officials. Dr. ...
... a vaccine against pneumococcal disease will be introduced for the ... 50 babies and small children a year and prevnt// illness ... national childhood immunisation programme. all babies will be vaccinated against ... months,from Sept.4. Apart from that, in a catch-up programme, infants ...
... analytical capabilities of high-tech laboratory tools, like computers, their ... they have// developed a second generation "lab on a ... first time rapidly and reliably sequences all mitochondrial DNA, ... Diagnostics. Mitochondria which are the energy-producing organelles in cells, ...
... tools such as computers with greater analytical capacities are ... generation "lab on a silicon chip" called the MitoChip ... mitochondrial DNA quickly and reliably. Their report will be ... Molecular Diagnostics. ,The mitochondria have their own ...
... a coordinated global plan, especially in developing countries to ... HIV/AIDS-related cases. ,57 countries, mostly in sub-Saharan ... facing acute shortage. Over 4 million workers are needed ... Train, Retain’ is an essential part of its effort ...
... latest example of growing online interaction between Britain and ... hour for online tuition on various subjects from teachers ... have been receiving such one-to-one tuition using Internet telephony ... employs teachers who work in shifts. ,While ...
Cached Medicine News:Health News:Global avian flu database 2Health News:Global avian flu database 3Health News:Global avian flu database 4Health News:Immunisation programme to include vaccine against Pneumococcal disease 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 3Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 4Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:British Pupils Opt for Online Tuition from India 2
... The AutoPulse Resuscitation System consists of the ... assembly and a rechargeable battery pack with ... is designed for adults with weight up ... 29.9 to 51.2 inches (76 to 130 ...
... The AI6 is an integrated system ... the way you want it. You no ... ,Standard measurements of arterial inflow with and ... need to choose the time for measurements ...
... The CVS4 Complete Vascular System combines cutting ... is a computerized peripheral vascular package available in ... open format which allows you to do vascular ... used to, while storing patient waveforms and data ...
... System eliminates the guesswork of Ventricular Restoration ... SVR System is a comprehensive surgical therapy ... Studies have shown that surgically restoring a ... shape by using the SVR System and ...
Medicine Products: